Sign Up to like & get
recommendations!
1
Published in 2020 at "Current Medical Science"
DOI: 10.1007/s11596-020-2266-1
Abstract: Although the advent of tyrosine kinase inhibitors (TKIs) has dramatically improved the survival of patients with chronic myeloid leukaemia (CML), acquired drug resistance and TKI-insensitive leukaemic stem cells (LSCs) remain major obstacles to a CML…
read more here.
Keywords:
k562 cells;
aicar;
aicar decitabine;
sensitivity k562 ... See more keywords